Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.

ERALP Y., Smith T., Kau S., Valero V., Buzdar A., Hortobagyi G., ...More

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 22
• City: Louisiana
• Country: United States Of America
• Acibadem Mehmet Ali Aydinlar University Affiliated: No